Structural basis for cross-group recognition of an influenza virus hemagglutinin antibody that targets postfusion stabilized epitope
PLOS Pathogens · 09.08.2023 · 19 (8) · e1011554
DOI: 10.1371/journal.ppat.1011554 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 09.08.2023. Verfasst von Keisuke Tonouchi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan. Hauptthemen laut MEDLINE: Antibodies, Viral, Influenza, Human, Orthomyxoviridae. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, JSPS KAKENHI, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Plasticity of influenza virus hemagglutinin (HA) conformation increases an opportunity to generate conserved non-native epitopes with unknown functionality. Here, we have performed an in-depth analysis of human monoclonal antibodies against a stem-helix region that is occluded in native prefusion yet exposed in postfusion HA. A stem-helix antibody, LAH31, provided IgG Fc-dependent cross-group protection by targeting a stem-helix kinked loop epitope, with a unique structure emerging in the postfusion state. The structural analysis and molecular modeling revealed key contact sites responsible for the epitope specificity and cross-group breadth that relies on somatically mutated light chain. LAH31 was inaccessible to the native prefusion HA expressed on cell surface; however, it bound to the HA structure present on infected cells with functional linkage to the Fc-mediated clearance. Our study uncovers a novel non-native epitope that emerges in the postfusion HA state, highlighting the utility of this epitope for a broadly protective antigen design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan.
- Department of Life Science and Medical Bioscience, Waseda University, Shinjuku, Tokyo, Japan.
- Laboratory of Medical Virology, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan.
- Laboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics research, National Institutes of Biomedical Innovation, Health and Nutrition; Saito-Asagi, Ibaraki City, Osaka, Japan.
- Computational Bio Big-Data Open Innovation Laboratory (CBBD-OIL), National Institute of Advanced Industrial Science and Technology, Shinjuku, Tokyo, Japan.
- Research Organization for Nano and Life Innovation, Waseda University, Shinjuku, Tokyo, Japan.
Förderung
- Japan Agency for Medical Research and Development
- JSPS KAKENHI
- Japan Society for the Promotion of Science
- Takeda science foundation
- AMED
Zitieren
APA
Tonouchi, K., Adachi, Y., Suzuki, T., Kuroda, D., Nishiyama, A., Yumoto, K., Takeyama, H., Suzuki, T., Hashiguchi, T., & Takahashi, Y. (2023). Structural basis for cross-group recognition of an influenza virus hemagglutinin antibody that targets postfusion stabilized epitope. PLOS Pathogens, 19(8), e1011554. https://doi.org/10.1371/journal.ppat.1011554
Vancouver
Tonouchi K, Adachi Y, Suzuki T, Kuroda D, Nishiyama A, Yumoto K, et al. Structural basis for cross-group recognition of an influenza virus hemagglutinin antibody that targets postfusion stabilized epitope. PLOS Pathogens. 2023;19(8):e1011554. doi:10.1371/journal.ppat.1011554
BibTeX
@article{Tonouchi2023,
author = {Tonouchi, Keisuke and Adachi, Yu and Suzuki, Tateki and Kuroda, Daisuke and Nishiyama, Ayae and Yumoto, Kohei and Takeyama, Haruko and Suzuki, Tadaki and Hashiguchi, Takao and Takahashi, Yoshimasa},
title = {Structural basis for cross-group recognition of an influenza virus hemagglutinin antibody that targets postfusion stabilized epitope},
journal = {PLOS Pathogens},
year = {2023},
volume = {19},
number = {8},
pages = {e1011554},
doi = {10.1371/journal.ppat.1011554}
}
EUVIMED